Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasilios Kotsis

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
American Journal of Hypertension|May 31, 2006
The role of lipid-lowering treatment in carotid intima-media thicknessVasilios Kotsis
Current Pharmaceutical Design|March 20, 2019
Treatment of Hypertension Induced Target Organ DamageVasilios Kotsis
Journal of Hypertension|May 11, 2012
Is it feasible to correct all-cause mortality from masked hypertension for home blood pressure values?Vasilios Kotsis
Journal of Hypertension|February 12, 2025
Blood pressure phenotypes and day-night variability in acute ischemic stroke: is there any cardiovascular mortality link 10 years after?Christina Antza, Vasilios Kotsis
American Journal of Hypertension|February 16, 2011
Arterial stiffness, vascular aging, and intracranial large artery diseaseVasilios Kotsis, Stella Stabouli
Journal of Hypertension|August 6, 2015
Targeted blood pressure screening in children and adolescents: a justifiable option?Stella Stabouli, Vasilios Kotsis
Journal of Hypertension|December 20, 2015
The enigma of obesity-induced hypertension mechanisms in the youthVasilios Kotsis, Guido Grassi
The New England Journal of Medicine|July 10, 2014
Renal denervation for resistant hypertensionVasilios Kotsis, Stella Stabouli
Journal of Hypertension|September 10, 2011
J-curve for DBP and cardiovascular mortality in coronary artery disease patients: myth or realityVasilios Kotsis, Guido Grassi
Journal of Hypertension|November 7, 2009
Is low blood pressure the cause of an adverse outcome or an effect of the extended cardiovascular disease in the prognostic value of the blood pressure in ONTARGET trial?Vasilios Kotsis, Stella Stabouli
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
American Journal of Hypertension|May 31, 2006
The role of lipid-lowering treatment in carotid intima-media thicknessVasilios Kotsis
Current Pharmaceutical Design|March 20, 2019
Treatment of Hypertension Induced Target Organ DamageVasilios Kotsis
Journal of Hypertension|May 11, 2012
Is it feasible to correct all-cause mortality from masked hypertension for home blood pressure values?Vasilios Kotsis
Journal of Hypertension|February 12, 2025
Blood pressure phenotypes and day-night variability in acute ischemic stroke: is there any cardiovascular mortality link 10 years after?Christina Antza, Vasilios Kotsis
American Journal of Hypertension|February 16, 2011
Arterial stiffness, vascular aging, and intracranial large artery diseaseVasilios Kotsis, Stella Stabouli
Journal of Hypertension|August 6, 2015
Targeted blood pressure screening in children and adolescents: a justifiable option?Stella Stabouli, Vasilios Kotsis
Journal of Hypertension|December 20, 2015
The enigma of obesity-induced hypertension mechanisms in the youthVasilios Kotsis, Guido Grassi
The New England Journal of Medicine|July 10, 2014
Renal denervation for resistant hypertensionVasilios Kotsis, Stella Stabouli
Journal of Hypertension|September 10, 2011
J-curve for DBP and cardiovascular mortality in coronary artery disease patients: myth or realityVasilios Kotsis, Guido Grassi
Journal of Hypertension|November 7, 2009
Is low blood pressure the cause of an adverse outcome or an effect of the extended cardiovascular disease in the prognostic value of the blood pressure in ONTARGET trial?Vasilios Kotsis, Stella Stabouli
Pageof 14